Where it comes from
- Made in
- Ovary (granulosa cells at ovulation), intestine, kidney
- Sent out by
- A sharp burst in the follicle just before it ruptures
- Acts on
- Follicle wall
- Gut and kidney vessels
- Retina
What it does
In medicine
- It has no medicine of its own, and no human disease has been traced to EDN2; the endothelin receptor blockers used in lung and kidney disease bind the receptors it shares with endothelin-1 3
- Two residues separate the two peptides, and at ETA and ETB that difference does not show, so a pharmacologist treats them as one target 3
- Antibodies and assays cross-react between them, so a measurement reported as endothelin-1 may include endothelin-2; how much is not known 3
Beyond the body’s own use
- Mice whose granulosa cells cannot make endothelin-2 fail to rupture their follicles and ovulate poorly. That is the main reason anyone asks whether endothelin blockers could affect fertility, and no human study has tested it 1
- In the injured retina, photoreceptors switch on EDN2 and signal to the surrounding glia; it is used in animal work as a marker of photoreceptor stress rather than as a treatment target 2
- Nothing is in trials and nothing is claimed for it. The open question is whether a peptide this close to endothelin-1 has any job that is truly its own
Sources
- Cacioppo et al., Granulosa cell endothelin-2 expression is fundamental for ovulatory follicle rupture, Scientific Reports 2017
- Rattner & Nathans, The genomic response to retinal disease and injury, Journal of Neuroscience 2005
- Davenport et al., Update on endothelin receptor nomenclature, Pharmacological Reviews 2002
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.